$Cerevel Therapeutics Holdings (CERE.US)$ Director COLES N ANTHONY sold 50,000 shares of common stock on May 10, 2024 at an average price of $42.1025 for a total value of $2.11 million.
What is statement of changes in beneficial ownership of securities?
It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.